Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBeximco Pharma Regulatory News (BXP)

  • This share is currently suspended. It was suspended at a price of 42.50

Share Price Information for Beximco Pharma (BXP)

Share Price is delayed by 15 minutes
Get Live Data
42.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £189.60m
BXP Live PriceLast checked at - London Stock Exchange

Intraday Beximco Pharma Share Chart

Notice of AGM - Amendment

6 May 2008 10:58

Beximco Pharmaceuticals Ltd06 May 2008 This announcement replaces RNS number 7576T and changes the Record Date to 2July 2008. BEXIMCO PHARMACEUTICALS LIMITED 17, DHANMONDI R.A, ROAD NO. 2, DHAKA-1205 NOTICE OF THE THIRTY-SECOND ANNUAL GENERAL MEETING Notice is hereby given that the THIRTY-SECOND ANNUAL GENERAL MEETING of theShareholders of Beximco Pharmaceuticals Limited will be held on Thursday, the21st August, 2008 at 10.30 a.m. at 1, Shahbag C/A, Dhaka to transact thefollowing business: AGENDA 1. To receive, consider and adopt the Audited Financial Statements of the Company for the year ended 31st December, 2007 together with reports of the Auditors and the Directors thereon. 2. To elect Directors. 3. To declare 5% Cash and 10% Stock Dividend. 4. To appoint Auditors for the year 2008 and to fix their remuneration. 5. To transact any other business of the Company with the permission of the Chair. By order of the Board, Sd/-Dated: 6th May, 2008 (MD. ASAD ULLAH, FCS) Company Secretary NOTES: (1) The Record Date shall be on 2nd July, 2008. The Shareholders whose nameswill appear in the Share Register of the Company or in the Depository Registeron that date will be entitled to attend at the Annual General Meeting and toreceive the dividend. (2) A member entitled to attend and vote at the General Meeting may appoint aProxy to attend and vote in his/her stead. The Proxy Form, duly stamped, must bedeposited at the Registered office of the Company not later than 48 hours beforethe time fixed for the meeting. (3) Admission to the meeting room will be strictly on production of theattendance slip sent with the Notice as well as verification of signature ofMember(s) and/or proxy-holder(s). This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Nov 20207:00 amRNSNotice of AGM
16th Nov 20207:00 amRNSResults for First Quarter Ended 30 September 2020
13th Nov 20207:00 amRNSResults for First Quarter Ended 30 September 2020
11th Nov 20207:00 amRNSResults for the year ended 30 June 2020
5th Nov 20204:40 pmRNSSecond Price Monitoring Extn
5th Nov 20204:35 pmRNSPrice Monitoring Extension
5th Nov 20202:40 pmRNSMOU with SII and GOB for COVID-19 vaccine
29th Oct 20207:00 amRNSNotification of Preliminary Results and AGM
21st Sep 20207:00 amRNSBeximco Pharma receives eighth FDA approval
28th Aug 202011:06 amRNSSecond Price Monitoring Extn
28th Aug 202011:00 amRNSPrice Monitoring Extension
28th Aug 20208:31 amRNSBeximco and SII to cooperate on a COVID-19 vaccine
30th Jul 20207:00 amRNSBoard Change
23rd Jun 20207:00 amRNSQ3 Financial Results and Business Update
21st May 20207:00 amRNSWorld’s first generic remdesivir for COVID-19
4th May 20207:00 amRNSCOVID-19 Update
30th Mar 20207:00 amRNSBeximco donates PPE to healthcare professionals
24th Feb 20207:00 amRNSBeximco announces Commercial Agreement with Mylan
29th Jan 20207:00 amRNSHalf Year Results 2019-20
20th Jan 202011:06 amRNSPayment of Cash Dividend
23rd Dec 201910:46 amRNSAGM Statement
19th Nov 20198:57 amRNSAGM Notification
14th Nov 20197:00 amRNSResults for First Quarter Ended 30 September 2019
11th Nov 20197:00 amRNSResults for the 12 month period ended 30 June 2019
29th Oct 20197:00 amRNSNotification of Preliminary Results and AGM
8th Aug 20199:18 amRNSUpdate on Dividend and Tax legislation changes
30th Jul 20197:00 amRNSBeximco launches fifth product in the US market
18th Jul 20194:01 pmRNSDividend and Tax changes for Bangladesh companies
29th Apr 20197:00 amRNS3rd Quarter Results
24th Apr 20197:00 amRNSBeximco receives FDA approval for Cyproheptadine
20th Feb 20197:00 amRNSBeximco Pharma to Acquire Eight ANDAs from Sandoz
4th Feb 201911:32 amRNSAppointment of Broker
31st Jan 20197:00 amRNSHalf Year Results 2018-19
22nd Jan 20197:00 amRNSPayment of Cash Dividend
27th Dec 20187:00 amRNSAGM Statement
27th Dec 20187:00 amRNSEGM Statement
30th Nov 20187:00 amRNSEGM Notification
30th Nov 20187:00 amRNSAGM Notification
29th Nov 20188:30 amRNSBeximco Pharma wins at Scrip Awards 2018
14th Nov 20187:00 amRNSResults for First Quarter Ended 30 September 2018
7th Nov 20187:00 amRNSResults for the 12 month period ended 30 June 2018
26th Oct 20187:00 amRNSNotification of Preliminary Results and AGM
30th Jul 20187:00 amRNSUS FDA Approves Beximco Pharma's Nadolol Tablets
23rd Jul 20187:00 amRNSCommences export of fourth product to the US
27th Apr 20187:00 amRNS3rd Quarter Results
23rd Apr 20187:00 amRNSCommences Export of Third Product to the US Market
3rd Apr 20187:00 amRNSCompletion of the Acquisition of Nuvista Pharma
30th Jan 20187:00 amRNSHalf Year Results 2017-18
19th Jan 20187:00 amRNSAcquisition of a Majority Stake in Nuvista Pharma
19th Jan 20187:00 amRNSPayment of Cash Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.